Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Selective receptor modulators pharmacology

Hall JM, Korach KS (2003) Selective sex steroid receptor modulators. In Offermanns S, Rosenthal W (eds) Encyclopedic Reference of Molecular Pharmacology. Springer Verlag, Heidelberg, Germany... [Pg.1117]

Clinical Pharmacology of Selective Estrogen Receptor Modulators (SERMs)... [Pg.63]

Buelke-Sam J, Bryant HU, Francis PC (1998) The selective estrogen receptor modulator, raloxifene an overview of nonclinical pharmacology and reproductive and developmental testing. Reprod Toxicol 12 217-221... [Pg.140]

Pharmacology Raloxifene is a selective estrogen receptor modulator (SERM) that reduces resorption of bone and decreases overall bone turnover. [Pg.188]

Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L Jr. A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update 2000 6(3) 212-24. [Pg.300]

Tyrosine Kinase Inhibitors and Selective Estrogen Receptor Modulators A Clinical Pharmacology Laboratory Perspective... [Pg.197]

Nilsson S et al (2005) Oestrogen receptors and selective oestrogen receptor modulators molecular and cellular pharmacology. Basic Clin Pharmacol Toxicol 96 15-25... [Pg.246]

There also exist a class of ligands referred to as SERMs (selective estrogen receptor modulators) that display tissue-selective pharmacology [13]. Raloxifene and tamoxifen are two clinically used SERMs for which structures are available. Crystal structures of the estrogen receptor bound to different ligands (estradiol, tamoxifen, or raloxifene) reveal that ligands of different sizes and shapes induce a spectrum of receptor conformational states. These states can be interpreted by the cellular complexion of co-regulators and the environment of the local promoter of... [Pg.15]

Waif, A.A., Rhodes, M.E. and Frye, C.A. (2004) Antidepressant effects of ERp-selective estrogen receptor modulators in the forced swim test. Pharmacology, Biochemistry, and Behavior, 78, 523-529. [Pg.61]

Pedersen, P.C., Gerrits, M., Watson, N. and Bjarnason, K. (2002) Levormeloxifene safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator. British Journal of Clinical Pharmacology, 53, 284-295. [Pg.194]

Kim, J., Wu, D., Hwang, D.J., Miller, D.D. and Dalton, J.T. (2005) The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromefhyl-phenylj-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators. The Journal of Pharmacology and Experimental Therapeutics, 315, 230-239. [Pg.296]

D. D. and Dalton, J.T. (2005) A selective androgen receptor modulator for hormonal male contraception. The Journal of Pharmacology and Experimental Therapeutics, 312, 546-553. [Pg.296]

See other pages where Selective receptor modulators pharmacology is mentioned: [Pg.156]    [Pg.899]    [Pg.5]    [Pg.63]    [Pg.77]    [Pg.78]    [Pg.91]    [Pg.116]    [Pg.123]    [Pg.250]    [Pg.971]    [Pg.555]    [Pg.182]    [Pg.470]    [Pg.1029]    [Pg.336]    [Pg.85]    [Pg.224]    [Pg.221]    [Pg.899]    [Pg.262]    [Pg.157]    [Pg.1068]    [Pg.443]    [Pg.1041]    [Pg.137]    [Pg.426]    [Pg.194]    [Pg.295]   
See also in sourсe #XX -- [ Pg.312 ]



SEARCH



Pharmacologic modulation

Receptor pharmacology

Selective receptors

Selectivity pharmacological

© 2024 chempedia.info